COSTS OF ABSENTEEISM IN PSORIATIC AND ENTEROPATHIC ARTHROPATHIES BASED ON REAL-LIFE DATA FROM POLAND'S SOCIAL INSURANCE INSTITUTION DATABASE IN 2013
Author(s)
Kawalec P, Malinowski K
Jagiellonian University Medical Collage Institute of Public Health, Krakow, Poland
OBJECTIVES: The aim of this study was to assess the indirect costs caused by absenteeism associated with psoriatic and enteropathic arthropathies from the perspective of the Social Insurance Institution (ZUS) in Poland. METHODS: The estimates were based on data from the year 2013 concerning sick leave and the amount of short-term disability, the sufferers of which claim rehabilitation benefit, and the amount of long-term disability (permanent or fixed time), the sufferers of which claim disability pension. Costs calculated taking into account Gross Domestic Product (GDP) per capita equaled €10 278, Gross Value Added (GVA) per worker equaled €24 680 and Gross Income (GI) per worker equaled €7 339 were presented in 2013 prices. RESULTS: Total indirect costs of psoriatic and enteropathic arthropathies in the year 2013 calculated using GDP per capita, GVA and GI per worker in Poland were €7 341 217, €17 628 441 and €5 242 346, respectively. The highest component of indirect costs was permanent long-term disability (43%). Fixed period long-term disability and short-term disability costs constitute 20% and 9% of total indirect costs, respectively. In 2013 Poland’s Social Insurance Institution database reported 2 100 patients that had 4 922 sick leave episodes, 180 short-term disability episodes and 80 long-term disability episodes. Indirect costs per patient associated with sick leave were €1 030, €2 474 and €736 calculated using GDP, GVA and GI, respectively. Indirect costs per patient associated with short-term disability were €298, €715 and €212 respectively and associated with long-term disability were as high as €2 168, €5 206 and €1 548, respectively. CONCLUSIONS: Psoriatic and enteropathic arthropathies in Poland generated high indirect costs. The main component was permanent long-term disability; short-term disability generated lower costs of lost productivity. The highest cost per patient was generated by permanent long-term disability.
Conference/Value in Health Info
2015-11, ISPOR Europe 2015, Milan, Italy
Value in Health, Vol. 18, No. 7 (November 2015)
Code
PSY40
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Systemic Disorders/Conditions